Antibiotic coverage for empyema
"empyema" AND "antibiotic"
| Clinical Setting | Likely Organisms |
|---|---|
| Community-acquired pneumonia | S. pneumoniae, S. aureus, H. influenzae |
| Aspiration / lung abscess | Mixed oropharyngeal anaerobes (Fusobacterium, Prevotella, Peptostreptococcus, Bacteroides fragilis) |
| Chest trauma | S. aureus, gram-negative bacilli |
| Recent thoracotomy | Gram-negative bacilli |
| Esophageal rupture | Mixed oropharyngeal flora |
| Hospital-acquired / postprocedure | MRSA, Pseudomonas aeruginosa |
| HIV / immunocompromised | TB, fungal organisms |
⚠️ Metronidazole alone is inadequate — aerobes are frequently co-present and not covered. — Murray & Nadel's Textbook of Respiratory Medicine
| Scenario | Regimen |
|---|---|
| Community-acquired, no MRSA risk | Ampicillin-sulbactam or piperacillin-tazobactam or clindamycin |
| Hospital-acquired / postprocedure | Vancomycin + piperacillin-tazobactam (or cefepime/carbapenem) |
| GAS empyema | Penicillin G IV ± clindamycin |
| Anaerobic (aspiration) | β-lactam/β-lactamase inhibitor or clindamycin |
| Penicillin allergy (non-anaphylactic) | 1st-gen cephalosporin or clindamycin |
| Penicillin allergy (anaphylactic) + serious infection | Vancomycin + aztreonam ± metronidazole |